Publication Date: 1/6/2010
- November 9, 2009 November is American Diabetes Month®--a time to shine a spotlight on a serious disease that leads to potentially life-threatening complications. [Story at ADA website: American Diabetes Month.]
- November 4, 2009 The FDA has expanded the indication and prescribing language for the type 2 diabetes drug Byetta, extending its approval to use as monotherapy for glycemic control in adults. The updated warning label includes a pancreatitis caution and an expansion of an existing warning for patients with renal impairment. [Story at Medical News: FDA Okays Diabetes Drug for First-Line Use, Adds Warning.]
